Figure 3From: Clinical significance of day 5 peripheral blast clearance rate in the evaluation of early treatment response and prognosis of patients with acute myeloid leukemiaSurvival analysis of whole cohort patients. (A) OS of patients subdivided into high (≥99.55%) and low (<99.55%) D5-PBCR groups, P = 0.011. (B) RFS of patients subdivided into high (≥99.55%) and low (<99.55%) D5-PBCR groups, P = 0.026.Back to article page